These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 9140120)
1. Immunoreactivity of recombinant human glandular kallikrein using monoclonal antibodies raised against prostate-specific antigen. Eerola R; Piironen T; Pettersson K; Lövgren J; Vehniäinen M; Lilja H; Dowell B; Lövgren T; Karp M Prostate; 1997 May; 31(2):84-90. PubMed ID: 9140120 [TBL] [Abstract][Full Text] [Related]
2. Determination and analysis of antigenic epitopes of prostate specific antigen (PSA) and human glandular kallikrein 2 (hK2) using synthetic peptides and computer modeling. Piironen T; Villoutreix BO; Becker C; Hollingsworth K; Vihinen M; Bridon D; Qiu X; Rapp J; Dowell B; Lövgren T; Pettersson K; Lilja H Protein Sci; 1998 Feb; 7(2):259-69. PubMed ID: 9521101 [TBL] [Abstract][Full Text] [Related]
3. Cross-reactivity of ten anti-prostate-specific antigen monoclonal antibodies with human glandular kallikrein. Corey E; Buhler KR; Vessella RL Urology; 1997 Oct; 50(4):567-71; discussion 571-2. PubMed ID: 9338733 [TBL] [Abstract][Full Text] [Related]
4. Production of recombinant PSA and HK2 and analysis of their immunologic cross-reactivity. Lövgren J; Piironen T; Overmo C; Dowell B; Karp M; Pettersson K; Lilja H; Lundwall A Biochem Biophys Res Commun; 1995 Aug; 213(3):888-95. PubMed ID: 7544581 [TBL] [Abstract][Full Text] [Related]
5. Polyclonal and monoclonal antibodies to prostate-specific antigen can cross-react with human kallikrein 2 and human kallikrein 1. Finlay JA; Day JR; Rittenhouse HG Urology; 1999 Apr; 53(4):746-51. PubMed ID: 10197850 [TBL] [Abstract][Full Text] [Related]
6. Western blotting analysis of antibodies to prostate-specific antigen: cross-reactivity with human kallikrein-2. Wang TJ; Linton HJ; Rittenhouse HG; Wolfert RL Tumour Biol; 1999; 20 Suppl 1():75-8. PubMed ID: 10628412 [TBL] [Abstract][Full Text] [Related]
7. Immunofluorometric assay for sensitive and specific measurement of human prostatic glandular kallikrein (hK2) in serum. Piironen T; Lövgren J; Karp M; Eerola R; Lundwall A; Dowell B; Lövgren T; Lilja H; Pettersson K Clin Chem; 1996 Jul; 42(7):1034-41. PubMed ID: 8674186 [TBL] [Abstract][Full Text] [Related]
8. Development of monoclonal antibodies specific for human glandular kallikrein (hK2): development of a dual antibody immunoassay for hK2 with negligible prostate-specific antigen cross-reactivity. Finlay JA; Evans CL; Day JR; Payne JK; Mikolajczyk SD; Millar LS; Kuus-Reichel K; Wolfert RL; Rittenhouse HG Urology; 1998 May; 51(5):804-9. PubMed ID: 9610595 [TBL] [Abstract][Full Text] [Related]
9. Development of an ultrasensitive immunoassay for human glandular kallikrein with no cross-reactivity from prostate-specific antigen. Black MH; Magklara A; Obiezu CV; Melegos DN; Diamandis EP Clin Chem; 1999 Jun; 45(6 Pt 1):790-9. PubMed ID: 10351987 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of a human prostate-specific glandular kallikrein, hK2, in E. coli and generation of antibodies. Saedi MS; Cass MM; Goel AS; Grauer L; Hogen KL; Okaneya T; Griffin BY; Klee GG; Young CY; Tindall DJ Mol Cell Endocrinol; 1995 Apr; 109(2):237-41. PubMed ID: 7664987 [TBL] [Abstract][Full Text] [Related]
11. Characterization of monoclonal antibodies for prostate-specific antigen and development of highly sensitive free prostate-specific antigen assays. Black MH; Grass CL; Leinonen J; Stenman UH; Diamandis EP Clin Chem; 1999 Mar; 45(3):347-54. PubMed ID: 10053035 [TBL] [Abstract][Full Text] [Related]
13. Epitope analysis of a prostate-specific antigen (PSA) C-terminal-specific monoclonal antibody and new aspects for the discrepancy between equimolar and skewed PSA assays. Nagasaki H; Watanabe M; Komatsu N; Kaneko T; Dubé JY; Kajita T; Saitoh Y; Ohta Y Clin Chem; 1999 Apr; 45(4):486-96. PubMed ID: 10102908 [TBL] [Abstract][Full Text] [Related]
14. Human Kallikrein 2 (hK2) and prostate-specific antigen (PSA): two closely related, but distinct, kallikreins in the prostate. Rittenhouse HG; Finlay JA; Mikolajczyk SD; Partin AW Crit Rev Clin Lab Sci; 1998 Aug; 35(4):275-368. PubMed ID: 9759557 [TBL] [Abstract][Full Text] [Related]
15. Identification of human glandular kallikrein hK2 from LNCaP cells. Grauer LS; Charlesworth MC; Saedi MS; Finlay JA; Liu RS; Kuus-Reichel K; Young CY; Tindall DJ J Androl; 1996; 17(4):353-9. PubMed ID: 8889697 [TBL] [Abstract][Full Text] [Related]
16. Reactivity of anti-PSA monoclonal antibodies with recombinant human kallikrein-2. Leinonen J; Leinimaa M; Zhang WM; Piironen T; Pettersson K; Lilja H; Dowell B; Stenman UH Tumour Biol; 1999; 20 Suppl 1():35-7. PubMed ID: 10628407 [TBL] [Abstract][Full Text] [Related]
17. Human kallikrein 2 (hK2), but not prostate-specific antigen (PSA), rapidly complexes with protease inhibitor 6 (PI-6) released from prostate carcinoma cells. Saedi MS; Zhu Z; Marker K; Liu RS; Carpenter PM; Rittenhouse H; Mikolajczyk SD Int J Cancer; 2001 Nov; 94(4):558-63. PubMed ID: 11745444 [TBL] [Abstract][Full Text] [Related]
18. Relative affinity and specificity of monoclonal antibodies against prostate-specific antigen. Jette DC; Kreutz FT; Suresh MR Tumour Biol; 1999; 20 Suppl 1():24-7. PubMed ID: 10628405 [TBL] [Abstract][Full Text] [Related]
19. Activation of the zymogen form of prostate-specific antigen by human glandular kallikrein 2. Lövgren J; Rajakoski K; Karp M; Lundwall â ; Lilja H Biochem Biophys Res Commun; 1997 Sep; 238(2):549-55. PubMed ID: 9299549 [TBL] [Abstract][Full Text] [Related]
20. Analysis of monoclonal antibodies to prostate-specific antigen: reactivity with native and recombinant prostate-specific antigen. Zhou Z; Barnett TR; Very DL; Ng PC; Pellegrino CM; Davis G; Belenky A; Allard WJ; Yeung KK Tumour Biol; 1999; 20 Suppl 1():86-93. PubMed ID: 10628414 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]